From Wikipedia, the free encyclopedia
(Redirected from Draft:Imine reductase)
SkIRED
Streptomyces kanamyceticus R-selective imine reductase PDB: 3ZHB
Identifiers
EC no. 1.5.1.48
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / QuickGO
Search
PMC articles
PubMed articles
NCBI proteins

An imine reductase (IRED) is an enzyme that reduces imines to amines. [1] [2] This family of enzymes is employed in the industrial production of amine-containing pharmaceuticals. [3] The IRED enzymes that are found to catalyze both imine formation and imine reduction are called reductive aminases (RedAms).

Function

Imine reduction

IREDs were originally discovered in 2010 by screening bacterial strains for reducing activity on 2-methyl-1-pyrroline (2-MPN). [4] [5] Based on each member's ability to reduce 2-MPN to (R)- or (S)-2-methylpyrrolidine they are designated as R-selective or S-selective, respectively. [6] [7]

Reductive amination

IREDs have been employed to reduce imines formed from ketone-amine mixtures. [1] [2] The conversion is not a genuine reductive amination as only the second half of the two-part reaction is catalyzed. In 2017 an IRED was discovered that catalyzed both steps of reductive amination of a wide scope of ketone-amine pairs. [8] These are dubbed reductive aminases (RedAms). [1] [2] Engineered RedAms have been employed in industrial processes to support production of pharmaceuticals for clinical trials and commercial manufacturing. [9] [10]

Structure

IREDs are dimeric enzymes with each protomer having an N-terminal Rossmann nucleotide-binding domain and a C-terminal dimerization domain joined by a long interdomain α-helix. [3] [11] Each protomer's α-helical dimerization domain wraps around the interdomain helix of its dimer partner forming the substrate-binding cleft above the NAD(P)H cofactor binding site in the Rossmann domain. 3-Hydroxybutyrate dehydrogenases have similar N-terminal nucleotide-binding and C-terminal dimerization domains, but do not share the extensive dimerization interface of IREDs. [12]

See also

References

  1. ^ a b c Mangas-Sanchez, Juan; France, Scott P; Montgomery, Sarah L; Aleku, Godwin A; Man, Henry; Sharma, Mahima; Ramsden, Jeremy I; Grogan, Gideon; Turner, Nicholas J (2017). "Imine reductases (IREDs)". Current Opinion in Chemical Biology. 37: 19–25. doi: 10.1016/j.cbpa.2016.11.022. PMID  28038349.
  2. ^ a b c Lenz, Maike; Borlinghaus, Niels; Weinmann, Leonie; Nestl, Bettina M. (2017). "Recent advances in imine reductase-catalyzed reactions". World Journal of Microbiology and Biotechnology. 33 (11): 199. doi: 10.1007/s11274-017-2365-8. ISSN  0959-3993. PMID  29022156. S2CID  255141416.
  3. ^ a b Gilio, Amelia K.; Thorpe, Thomas W.; Turner, Nicholas; Grogan, Gideon (2022). "Reductive aminations by imine reductases: from milligrams to tons". Chemical Science. 13 (17): 4697–4713. doi: 10.1039/D2SC00124A. ISSN  2041-6520. PMC  9067572. PMID  35655886.
  4. ^ Mitsukura, Koichi; Suzuki, Mai; Tada, Kazuhiro; Yoshida, Toyokazu; Nagasawa, Toru (2010-08-12). "Asymmetric synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell catalyst of enantioselective imine reductase". Organic & Biomolecular Chemistry. 8 (20): 4533–4535. doi: 10.1039/C0OB00353K. ISSN  1477-0520. PMID  20820664.
  5. ^ Mitsukura, Koichi; Suzuki, Mai; Shinoda, Sho; Kuramoto, Tatsuya; Yoshida, Toyokazu; Nagasawa, Toru (2011-09-23). "Purification and Characterization of a Novel ( R )-Imine Reductase from Streptomyces sp. GF3587". Bioscience, Biotechnology, and Biochemistry. 75 (9): 1778–1782. doi: 10.1271/bbb.110303. ISSN  0916-8451. PMID  21897027.
  6. ^ Scheller, Philipp N.; Fademrecht, Silvia; Hofelzer, Sebastian; Pleiss, Jürgen; Leipold, Friedemann; Turner, Nicholas J.; Nestl, Bettina M.; Hauer, Bernhard (2014-10-13). "Enzyme Toolbox: Novel Enantiocomplementary Imine Reductases". ChemBioChem. 15 (15): 2201–2204. doi: 10.1002/cbic.201402213. ISSN  1439-4227. PMID  25163890. S2CID  42316871.
  7. ^ Fademrecht, Silvia; Scheller, Philipp N.; Nestl, Bettina M.; Hauer, Bernhard; Pleiss, Jürgen (2016). "Identification of imine reductase-specific sequence motifs". Proteins: Structure, Function, and Bioinformatics. 84 (5): 600–610. doi: 10.1002/prot.25008. ISSN  0887-3585. PMID  26857686. S2CID  10149699.
  8. ^ Aleku, Godwin A.; France, Scott P.; Man, Henry; Mangas-Sanchez, Juan; Montgomery, Sarah L.; Sharma, Mahima; Leipold, Friedemann; Hussain, Shahed; Grogan, Gideon; Turner, Nicholas J. (2017). "A reductive aminase from Aspergillus oryzae". Nature Chemistry. 9 (10): 961–969. Bibcode: 2017NatCh...9..961A. doi: 10.1038/nchem.2782. ISSN  1755-4330. PMID  28937665. S2CID  33498137.
  9. ^ Schober, Markus; MacDermaid, Chris; Ollis, Anne A.; Chang, Sandy; Khan, Diluar; Hosford, Joseph; Latham, Jonathan; Ihnken, Leigh Anne F.; Brown, Murray J. B.; Fuerst, Douglas; Sanganee, Mahesh J.; Roiban, Gheorghe-Doru (2019-09-16). "Chiral synthesis of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine reductase". Nature Catalysis. 2 (10): 909–915. doi: 10.1038/s41929-019-0341-4. ISSN  2520-1158. S2CID  202580808.
  10. ^ Kumar, Rajesh; Karmilowicz, Michael J.; Burke, Dylan; Burns, Michael P.; Clark, Leslie A.; Connor, Christina G.; Cordi, Eric; Do, Nga M.; Doyle, Kevin M.; Hoagland, Steve; Lewis, Chad A.; Mangan, David; Martinez, Carlos A.; McInturff, Emma L.; Meldrum, Kevin (2021-09-21). "Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor". Nature Catalysis. 4 (9): 775–782. doi: 10.1038/s41929-021-00671-5. ISSN  2520-1158. S2CID  237588372.
  11. ^ Rodríguez-Mata, María; Frank, Annika; Wells, Elizabeth; Leipold, Friedemann; Turner, Nicholas J.; Hart, Sam; Turkenburg, Johan P.; Grogan, Gideon (2013-07-22). "Structure and Activity of NADPH-Dependent Reductase Q1EQE0 from Streptomyces kanamyceticus , which Catalyses the R -Selective Reduction of an Imine Substrate". ChemBioChem. 14 (11): 1372–1379. doi: 10.1002/cbic.201300321. ISSN  1439-4227. PMID  23813853. S2CID  205557837.
  12. ^ Lenz, Maike; Fademrecht, Silvia; Sharma, Mahima; Pleiss, Jürgen; Grogan, Gideon; Nestl, Bettina M (2018-04-01). "New imine-reducing enzymes from β -hydroxyacid dehydrogenases by single amino acid substitutions". Protein Engineering, Design and Selection. 31 (4): 109–120. doi: 10.1093/protein/gzy006. ISSN  1741-0126. PMID  29733377.
From Wikipedia, the free encyclopedia
(Redirected from Draft:Imine reductase)
SkIRED
Streptomyces kanamyceticus R-selective imine reductase PDB: 3ZHB
Identifiers
EC no. 1.5.1.48
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / QuickGO
Search
PMC articles
PubMed articles
NCBI proteins

An imine reductase (IRED) is an enzyme that reduces imines to amines. [1] [2] This family of enzymes is employed in the industrial production of amine-containing pharmaceuticals. [3] The IRED enzymes that are found to catalyze both imine formation and imine reduction are called reductive aminases (RedAms).

Function

Imine reduction

IREDs were originally discovered in 2010 by screening bacterial strains for reducing activity on 2-methyl-1-pyrroline (2-MPN). [4] [5] Based on each member's ability to reduce 2-MPN to (R)- or (S)-2-methylpyrrolidine they are designated as R-selective or S-selective, respectively. [6] [7]

Reductive amination

IREDs have been employed to reduce imines formed from ketone-amine mixtures. [1] [2] The conversion is not a genuine reductive amination as only the second half of the two-part reaction is catalyzed. In 2017 an IRED was discovered that catalyzed both steps of reductive amination of a wide scope of ketone-amine pairs. [8] These are dubbed reductive aminases (RedAms). [1] [2] Engineered RedAms have been employed in industrial processes to support production of pharmaceuticals for clinical trials and commercial manufacturing. [9] [10]

Structure

IREDs are dimeric enzymes with each protomer having an N-terminal Rossmann nucleotide-binding domain and a C-terminal dimerization domain joined by a long interdomain α-helix. [3] [11] Each protomer's α-helical dimerization domain wraps around the interdomain helix of its dimer partner forming the substrate-binding cleft above the NAD(P)H cofactor binding site in the Rossmann domain. 3-Hydroxybutyrate dehydrogenases have similar N-terminal nucleotide-binding and C-terminal dimerization domains, but do not share the extensive dimerization interface of IREDs. [12]

See also

References

  1. ^ a b c Mangas-Sanchez, Juan; France, Scott P; Montgomery, Sarah L; Aleku, Godwin A; Man, Henry; Sharma, Mahima; Ramsden, Jeremy I; Grogan, Gideon; Turner, Nicholas J (2017). "Imine reductases (IREDs)". Current Opinion in Chemical Biology. 37: 19–25. doi: 10.1016/j.cbpa.2016.11.022. PMID  28038349.
  2. ^ a b c Lenz, Maike; Borlinghaus, Niels; Weinmann, Leonie; Nestl, Bettina M. (2017). "Recent advances in imine reductase-catalyzed reactions". World Journal of Microbiology and Biotechnology. 33 (11): 199. doi: 10.1007/s11274-017-2365-8. ISSN  0959-3993. PMID  29022156. S2CID  255141416.
  3. ^ a b Gilio, Amelia K.; Thorpe, Thomas W.; Turner, Nicholas; Grogan, Gideon (2022). "Reductive aminations by imine reductases: from milligrams to tons". Chemical Science. 13 (17): 4697–4713. doi: 10.1039/D2SC00124A. ISSN  2041-6520. PMC  9067572. PMID  35655886.
  4. ^ Mitsukura, Koichi; Suzuki, Mai; Tada, Kazuhiro; Yoshida, Toyokazu; Nagasawa, Toru (2010-08-12). "Asymmetric synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell catalyst of enantioselective imine reductase". Organic & Biomolecular Chemistry. 8 (20): 4533–4535. doi: 10.1039/C0OB00353K. ISSN  1477-0520. PMID  20820664.
  5. ^ Mitsukura, Koichi; Suzuki, Mai; Shinoda, Sho; Kuramoto, Tatsuya; Yoshida, Toyokazu; Nagasawa, Toru (2011-09-23). "Purification and Characterization of a Novel ( R )-Imine Reductase from Streptomyces sp. GF3587". Bioscience, Biotechnology, and Biochemistry. 75 (9): 1778–1782. doi: 10.1271/bbb.110303. ISSN  0916-8451. PMID  21897027.
  6. ^ Scheller, Philipp N.; Fademrecht, Silvia; Hofelzer, Sebastian; Pleiss, Jürgen; Leipold, Friedemann; Turner, Nicholas J.; Nestl, Bettina M.; Hauer, Bernhard (2014-10-13). "Enzyme Toolbox: Novel Enantiocomplementary Imine Reductases". ChemBioChem. 15 (15): 2201–2204. doi: 10.1002/cbic.201402213. ISSN  1439-4227. PMID  25163890. S2CID  42316871.
  7. ^ Fademrecht, Silvia; Scheller, Philipp N.; Nestl, Bettina M.; Hauer, Bernhard; Pleiss, Jürgen (2016). "Identification of imine reductase-specific sequence motifs". Proteins: Structure, Function, and Bioinformatics. 84 (5): 600–610. doi: 10.1002/prot.25008. ISSN  0887-3585. PMID  26857686. S2CID  10149699.
  8. ^ Aleku, Godwin A.; France, Scott P.; Man, Henry; Mangas-Sanchez, Juan; Montgomery, Sarah L.; Sharma, Mahima; Leipold, Friedemann; Hussain, Shahed; Grogan, Gideon; Turner, Nicholas J. (2017). "A reductive aminase from Aspergillus oryzae". Nature Chemistry. 9 (10): 961–969. Bibcode: 2017NatCh...9..961A. doi: 10.1038/nchem.2782. ISSN  1755-4330. PMID  28937665. S2CID  33498137.
  9. ^ Schober, Markus; MacDermaid, Chris; Ollis, Anne A.; Chang, Sandy; Khan, Diluar; Hosford, Joseph; Latham, Jonathan; Ihnken, Leigh Anne F.; Brown, Murray J. B.; Fuerst, Douglas; Sanganee, Mahesh J.; Roiban, Gheorghe-Doru (2019-09-16). "Chiral synthesis of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine reductase". Nature Catalysis. 2 (10): 909–915. doi: 10.1038/s41929-019-0341-4. ISSN  2520-1158. S2CID  202580808.
  10. ^ Kumar, Rajesh; Karmilowicz, Michael J.; Burke, Dylan; Burns, Michael P.; Clark, Leslie A.; Connor, Christina G.; Cordi, Eric; Do, Nga M.; Doyle, Kevin M.; Hoagland, Steve; Lewis, Chad A.; Mangan, David; Martinez, Carlos A.; McInturff, Emma L.; Meldrum, Kevin (2021-09-21). "Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor". Nature Catalysis. 4 (9): 775–782. doi: 10.1038/s41929-021-00671-5. ISSN  2520-1158. S2CID  237588372.
  11. ^ Rodríguez-Mata, María; Frank, Annika; Wells, Elizabeth; Leipold, Friedemann; Turner, Nicholas J.; Hart, Sam; Turkenburg, Johan P.; Grogan, Gideon (2013-07-22). "Structure and Activity of NADPH-Dependent Reductase Q1EQE0 from Streptomyces kanamyceticus , which Catalyses the R -Selective Reduction of an Imine Substrate". ChemBioChem. 14 (11): 1372–1379. doi: 10.1002/cbic.201300321. ISSN  1439-4227. PMID  23813853. S2CID  205557837.
  12. ^ Lenz, Maike; Fademrecht, Silvia; Sharma, Mahima; Pleiss, Jürgen; Grogan, Gideon; Nestl, Bettina M (2018-04-01). "New imine-reducing enzymes from β -hydroxyacid dehydrogenases by single amino acid substitutions". Protein Engineering, Design and Selection. 31 (4): 109–120. doi: 10.1093/protein/gzy006. ISSN  1741-0126. PMID  29733377.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook